The needle free design and closed sealing mechanism help maximize safety and efficiency by:. This adapter plug attaches to the catheter hub for needle free, venous access. Benefits include:. It attaches to a catheter hub for needle free, venous access, and connects the catheter to an IV set. The MicroCLAVE Vial Adapter can be used for needle free aspiration of drug from drug vials, or for the needle free mixing of drug solutions in drug vials. Other benefits include:. The bag access device enables you to provide needle free injections of additives into fluid bags, and needle free filling of syringes from fluid bags.
We are Mon—Fri, am—pm ET. You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country.
Consequently, the information provided on the site in which you enter may not be suitable for use in your country. This site is intended for U.
Animal Healthcare Professionals. All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. All rights reserved. Home I.
Solutions I. Benefits include: Easy connection and disconnection Reduces risk of accidental needle stick exposures to staff Provides venous access Reduces risk of contamination, and patient infection, due to repeat needle sticks to the port Reduces risk of catheter occlusion by reducing flashback in the hub Prevents leaking of fluids, blood, and medication through a closed sealing mechanism, without the use of caps and tape Reduces cost by eliminating the use of needles.
Benefits include: Easy connection and disconnection Prevents leaking of fluids, blood, and medications through a closed sealing mechanism, without the use of caps and tape Reduces risk of contamination, and patient infection, due to repeat needle sticks to the port 7" tubing can be easily secured to patient to reduce risk of catheter pulling out Provides optional use of standard latex reseal port close to the vein Provides venous access Reduces risk of accidental needle stick exposure to staff Reduces the risk of catheter pulling out with luer lock feature.
Other benefits include: Reduces risk of contamination to vial and drug due to repeat needle sticks to the seal Prevents leaking due to repeat needle sticks to the seal, reducing loss of medications Allows for thick, viscous solutions to be drawn up easily Reduces staff exposure to hazardous chemicals such as blood or chemotherapy agents Reduces risk of accidental needle stick exposure to staff Reduces cost by eliminating the use of needles. Other benefits include: Prevents leaking due to repeat needle sticks to the ports, reducing loss of fluids and medications Reduces risk of contamination to bag, and patient infections, due to repeat needle sticks to the ports Reduces exposure to hazardous chemicals such as blood or chemotherapy agents to staff and clients Reduces risk of accidental needle stick exposure to staff Reduces cost by eliminating the use of needles.
Other benefits include: Reduces cost associated with extension sets; the longer set is useful for large animals and kennels Convenient and efficient piggybacking of additional fluids into primary line without the use of needles, caps, and tape Prevents leaking of fluids, blood, and medications through a closed sealing mechanism, without the use of caps and tape Reduces risk of contamination of bag, and patient infections, due to repeat needle sticks to the ports Reduces risk of accidental needle stick exposure to staff Reduces costs by eliminating the use of needles All products in the MicroCLAVE product line are supplied by AAH, which supports and invests in veterinary medicine.
Provides easy connection and disconnection without compromising sterility. United States Close X. For animals. For health. For you. This website is for U.For over thirty-five years, NP Medical has been improving lives by providing products that help patients receive affordable, life-sustaining therapy. We work closely with caregivers and patients to provide innovative, distinctive products that help reduce total cost of care in the clinical setting. Our solutions are intended to reduce complications, decrease caregiver errors and accidents, and promote positive patient outcomes.
We are always committed to quality patient care. Whether in a traditional setting or with emerging digital and homebased therapies, we innovate to deliver transformative data-enabled product solutions.
While being at the forefront of the digital transformation in healthcare, NP Medical continues to focus on…. We help lower total cost of care by enabling efficient workflows, reduced infection rates, and better outcomes.
In common use cases, we help reduce clinical variation with easy-to-use, easy-to-clean product solutions. NP Medical offers vascular access site management systems that are intended to provide complete, efficient solutions for caregivers — no matter the setting.
We offer multiple extension set configurations and also provide custom solutions in consultation with our customers. Toggle navigation. Enabling Clinical Benefits Today. Support best clinical practice aseptic techniques through design. Deliver best-in-class neutral needle-free connector performance. Provide multiple configurations for vascular access site management. And Tomorrow. Measurement of key physiological and therapy parameters. Translation of patient monitoring into insight for vascular access site management.
Simplification of vascular access site management through enabling product design. Explore the Possibilities. Solutions for Caregivers NP Medical offers vascular access site management systems that are intended to provide complete, efficient solutions for caregivers — no matter the setting.
Learn more. Components Needle-Free Connectors. Extension Sets. Pressure Activated Valves. Luer Activated Valves.
Inline Check Valves. Search Results.Needle-free injectors deliver the vaccine using a narrow stream of fluid to penetrate the skin, and deliver vaccine to the proper tissue depth. Since the first jet injectors were introduced in the s, the technology has evolved to a single-use, sterile, disposable syringe used with a reusable injector. These innovative needle-free injectors have proven to be a safe and effective method of administration.
Needle-Free Technology. Needle-Free Syringes Eliminate Needlestick Injuries, Reduce Needle Reuse and Cross-Contamination Needle-free injectors deliver the vaccine using a narrow stream of fluid to penetrate the skin, and deliver vaccine to the proper tissue depth. Why is Needle-Free Important? As many as million used needles are added to trash dumps and landfills every year as a result of vaccination. References United States. Center for Disease Control and Prevention. National Institute for Occupational Safety and Health.
American Journal of Industrial Medicine 48 6 : — Collins C. International Sharps Injury Prevention Society, n. United States. Sharps Safety Workbook. Jagger, J. Pugliese, G. Survey of the prevalence of immunization non-compliance due to needle fears in children and adults. Vaccine ; 30; Web.Though the pain they cause is minor and fleeting, a lot of people still find something pretty unsettling about needles.
When it comes to conducting a routine blood test, US-based company Tasso Inc. Its ping pong ball-sized HemoLink blood sampler can be operated by the patient at home, and needs only to be placed against the skin of the arm or abdomen for two minutes to do its job. The roots of HemoLink can be traced back to the Tasso founders' research in microfluids at the University of Wisconsin-Madison. It was here that observations of circulating tumor cells, immune cells and visions of a medical device startup spawned the beginnings of Tasso Inc.
HemoLink is designed as a low-cost, disposable device made from as few as six injection-molded plastic parts. Inside is a vacuum, which enables a small sample of blood to be drawn from tiny open channels into a small tube through a process known as capillary action. This process is made possible by forces that dictate the flow of tiny fluid streams, even against gravity.
The device can draw around 0. The company says that its target market will be people who need blood samples to be taken regularly, but not constantly, with the device being so simple to use that patients can take their own blood samples. This would remove the need for expensive cold-chain transportation.
Tasso Inc. If this eventuates, its benefits could be two-fold: easing the pain for needle-phobic patients and making healthcare cheaper and more accessible by eliminating countless trips to the doctor. LOG IN. Menu HOME. Search Query Submit Search. Facebook Twitter Flipboard LinkedIn. The HemoLink device can draw enough blood for certain routine tests without the need for needles Photo: David Tenenbaum. View 3 Images. Nick Lavars. Nick has been writing and editing at New Atlas for over six years, where he has covered everything from distant space probes to self-driving cars to oddball animal science.
Materials and methods: This retrospective analysis compared outcomes among patients of a large dialysis organization receiving in-center hemodialysis using a central venous catheter with either the Tego connector or standard catheter caps between October 1 and June 30, Incidence rates for intravenous IV antibiotic starts, receipt of an IV antibiotic course, positive blood cultures, mortality, and missed dialysis treatments were calculated, and incidence-rate ratios IRRs were estimated using Poisson regression models.
Utilization of erythropoiesis-stimulating agents ESAs and thrombolytics was described for each patient-month and compared using mixed linear models. Models were run without adjustment, adjusted for covariates that were imbalanced between cohorts, or fully adjusted for all potential confounders.
Results: The analysis comprised 10, Tego patients and 6, controls. Tego use was independently associated with decreased rate of missed dialysis treatments adjusted IRR 0. Tego use was associated with decreased likelihood of thrombolytic use adjusted per-month probability of 5.
Keywords: catheter, dialysis, end-stage renal disease, ESA, infection, mortality. Catheter occlusion due to thrombosis is another common issue, and can result in lower blood flow and dialysis inadequacy.
Recent initiatives to reduce rates of CVC use in HD patients have had some success, 910 although rates remain unacceptably high. Implementation was not universal, owing to delayed or absent uptake by individual facilities. However, within individual facilities, Tego connectors are nearly universally used or universally not used.
The resulting natural experiment forms the basis for rigorous evaluation of the comparative effectiveness of Tego versus standard catheter caps, an analysis that is lacking from the published literature; available studies have been small, and yielded equivocal results.
The goal of this retrospective analysis was to assess the comparative effectiveness of Tego versus standard catheter caps. In order to minimize any bias due to events that preceded the study, analysis was limited to catheters that were newly placed during the study period. Although catheter implantation-site information was not available for study patients, tunneled catheters within the upper central vasculature are almost universal within LDOs. Patients were therefore considered if they: 1 underwent CVC placement during the period from October 1, to June 30, ; 2 received in-center HD via said CVC for at least 21 days thereafter to avoid consideration of temporary catheters that may not have been left in place long enough to manifest adverse events ; 3 had available electronic health-record data regarding the catheter-cap type used ie, Tego or standard catheter cap ; and 4 did not switch in either direction between standard catheter cap and Tego-connector use within 21 days of first in-center HD with the new catheter.
CVCs in place prior to October 1, were not considered. However, patients with prior catheters were eligible for study if they underwent placement of a new catheter during the study period and met the aforementioned criteria; in these instances, patients entered the study at the time of the new catheter placement.Negative pressure and neutral needle free devices blood reflux
Catheters with standard caps were typically locked with unfractionated heparin, and catheters with Tego connectors were locked with saline, as per LDO policies and procedures. Patients were classified according to the catheter cap type that was placed at the dialysis session following catheter placement Tego versus standard catheter cap. By inclusionary restriction, the catheter type was maintained for at least 21 days thereafter see earlier.
Thereafter, patients remained assigned to their starting group for the remainder of the study. Patients who crossed over between exposure groups thereafter were censored 21 days after crossover; this lagged censoring was used to account for delays in disease manifestation, as infections may have initiated during use of the original cap type but not manifested until after switching.
At-risk time otherwise continued until censoring for change in dialysis access type, transfer of care, change in modality, transplant, withdrawal from dialysis, or end of the study June 30, Patients could therefore contribute a minimum of 21 days and a maximum of days of at-risk time. Occurrence of CRBSI was identified for each patient using three operational definitions: intravenous IV antibiotic start, receipt of an IV antibiotic course defined as patient having received two or more doses of IV antibiotic within a day periodor confirmed positive blood culture.
Of particular note, many dialysis patients particularly when faced with more severe symptoms will seek urgent care outside the dialysis facility eg, emergency department, hospital ; blood culture results from such visits are not available through LDO electronic health records. Death data were abstracted from the LDO electronic health record system. Missed treatments were also abstracted from LDO electronic health records. Missed treatment rate is important in its own right, because of implied effects on the adequacy of renal replacement therapy and also as a surrogate of hospitalization; sensitivity of LDO electronic health records for hospitalization events and particular cause-specific hospitalization events is poor.The Tego needlefree connector allows for significantly less catheter hub manipulation and minimizes the risk of catheter contamination and catheter-related bloodstream infections CRBSIs.
Reducing CRBSIs can reduce complications for your patients and costly scheduling disruptions for your clinic. Saline flush can help reduce the use of heparin. May help lower overall costs. Details Literature Clinical Evidence Reference.
Patented needlefree technology that provides a safe and effective microbial barrier for hemodialysis and apheresis applications. Remains in place during the entire hemodialysis or apheresis treatment period. Validated for continuous patient use for up to seven days. Silicone seal remains closed when not activated, closing the fluid path and eliminating blood exposure.
Clinical Advantages The Tego connector creates a mechanically and microbiologically closed system when attached to the hub of a catheter, eliminating open catheter hubs and lowering the chance of contamination and infection. Tego's saline flush option allows you to reduce risks and costs associated with heparin use. How it works. Accessing the Fluid Path: When Tego is not being accessed, the silicone seal forms a safe, swabbable barrier to bacterial ingress. Attaching Tego to a dialysis blood line activates the straight internal fluid path and creates a mechanically and microbiologically closed system.
Previous Next. Product Literature. Tego Needlefree Hemodialysis Connector. Tego Needlefree Apheresis Connector. Tego Directions For Use. White Papers. Clinical Reports. Testimonial from Dr. Krishnan M. Product Reference. Attach Tego to Patient's Catheter Use aseptic technique to remove from package.
Attach male luer of Tego to dialysis catheter. Access of the Tego either through a syringe, blood line, or vacutainer should be straight on, not at an angle. Do not overtighten your luers syringes, blood lines when connecting to the Tego. Be sure not to continue to turn after you feel the luer stop.
When using a luer slip vacutainer, only insert half-way with a slight turn clockwise into the Tego and then turn clockwise to come out. Flush the Tego with Normal Saline When giving the post 10 mL saline lock through the Tego, leave a minimal amount of fluid in the tip of the syringe, as not to bottom out the syringe and cause reflux or a rebound effect.
Extending IV safety and flexibility to accommodate various clinical settings. Needlefree IV access, site securement and protection in a convenient kit. Designed to reduce the potential for catheter-related complications and unscheduled restarts and to reduce costs. Needleless connectors offer a safe way to access IV lines without the use of a needle, which greatly reduces the risk of accidental needlestick injuries.
Braun offers a variety of needleless connector devices to meet the desired need of individual facilities. Designed to make access clear and easy. Needle-free — and hassle-free — IV connection adaptability and safety. Streamline your practice and ordering process while delivering patient safety by minimizing exposure to infection-causing contaminates with preassembled sets. The DOCit device is intended to disinfect and clean syringe tips and male luer connectors.
The HubScrub device is intended to disinfect and clean needleless connectors and stopcocks. Braun blood sets offer superior micron filtration in single or dual spike designs. Our broad line of blood sets include: - Y-site - Straight - Pump - Hand pump.
Filtration for various blood IV administration needs.